NexGel (NXGL) Competitors $2.60 -0.02 (-0.76%) As of 07/3/2025 01:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. INO, TELA, EDAP, MLSS, MDAI, SURG, HYPR, NEPH, ICCM, and APTShould you be buying NexGel stock or one of its competitors? The main competitors of NexGel include Inovio Pharmaceuticals (INO), TELA Bio (TELA), Edap Tms (EDAP), Milestone Scientific (MLSS), Spectral AI (MDAI), SurgePays (SURG), Hyperfine (HYPR), Nephros (NEPH), IceCure Medical (ICCM), and Alpha Pro Tech (APT). These companies are all part of the "medical equipment" industry. NexGel vs. Its Competitors Inovio Pharmaceuticals TELA Bio Edap Tms Milestone Scientific Spectral AI SurgePays Hyperfine Nephros IceCure Medical Alpha Pro Tech Inovio Pharmaceuticals (NASDAQ:INO) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment. Do analysts prefer INO or NXGL? Inovio Pharmaceuticals currently has a consensus price target of $9.75, suggesting a potential upside of 579.44%. Given Inovio Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts plainly believe Inovio Pharmaceuticals is more favorable than NexGel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inovio Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50NexGel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in INO or NXGL? 26.8% of Inovio Pharmaceuticals shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 2.3% of Inovio Pharmaceuticals shares are held by company insiders. Comparatively, 20.6% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, INO or NXGL? Inovio Pharmaceuticals has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, NexGel has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500. Does the media refer more to INO or NXGL? In the previous week, Inovio Pharmaceuticals had 8 more articles in the media than NexGel. MarketBeat recorded 8 mentions for Inovio Pharmaceuticals and 0 mentions for NexGel. Inovio Pharmaceuticals' average media sentiment score of 0.15 beat NexGel's score of 0.00 indicating that Inovio Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Inovio Pharmaceuticals Neutral NexGel Neutral Is INO or NXGL more profitable? Inovio Pharmaceuticals has a net margin of 0.00% compared to NexGel's net margin of -30.80%. NexGel's return on equity of -54.95% beat Inovio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Inovio PharmaceuticalsN/A -136.93% -89.99% NexGel -30.80%-54.95%-27.84% Which has higher earnings & valuation, INO or NXGL? NexGel has higher revenue and earnings than Inovio Pharmaceuticals. NexGel is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInovio Pharmaceuticals$220K239.19-$107.25M-$3.19-0.45NexGel$8.69M2.29-$3.28M-$0.45-5.78 SummaryInovio Pharmaceuticals beats NexGel on 10 of the 16 factors compared between the two stocks. Get NexGel News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNexGelMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.28M$6.95B$5.56B$9.04BDividend YieldN/A1.21%5.24%4.01%P/E Ratio-5.7826.6327.6420.24Price / Sales2.2998.67416.55117.31Price / CashN/A21.0936.8958.10Price / Book2.894.748.035.67Net Income-$3.28M$173.18M$3.18B$249.21M7 Day Performance8.33%1.33%2.93%3.28%1 Month Performance12.55%-1.67%1.72%3.95%1 Year Performance17.65%25.08%34.39%20.98% NexGel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNexGel0.4069 of 5 stars$2.60-0.8%N/A+17.6%$20.28M$8.69M-5.7810INOInovio Pharmaceuticals3.8605 of 5 stars$1.93-1.5%$9.75+405.2%-83.9%$71.88M$220K-0.61320News CoverageGap DownTELATELA Bio2.5772 of 5 stars$1.73+4.8%$7.25+319.1%-52.6%$65.27M$71.22M-1.23120Gap UpEDAPEdap Tms2.3919 of 5 stars$1.72+1.3%$8.50+394.2%-69.0%$63.49M$69.18M-2.77230MLSSMilestone Scientific2.8959 of 5 stars$0.80-9.1%$1.25+56.4%+1.5%$62.70M$8.61M-11.4130Negative NewsGap UpMDAISpectral AI2.9885 of 5 stars$2.05-6.4%$4.75+131.7%+40.9%$55.44M$29.58M-3.8083News CoverageAnalyst RevisionSURGSurgePays3.0518 of 5 stars$2.73+1.1%$9.00+229.7%+7.9%$55.11M$60.88M-0.9840HYPRHyperfine1.8859 of 5 stars$0.690.0%$1.06+52.8%-21.1%$54M$12.89M-1.28190NEPHNephros0.8576 of 5 stars$4.29-14.2%$5.00+16.6%+96.2%$53M$15.52M61.2930News CoverageGap DownHigh Trading VolumeICCMIceCure Medical2.1056 of 5 stars$0.92-3.3%$2.50+171.7%+45.1%$52.79M$3.29M-3.2960News CoverageAPTAlpha Pro Tech1.6912 of 5 stars$4.76+0.2%N/A-17.0%$51.60M$58.18M12.86120 Related Companies and Tools Related Companies INO Alternatives TELA Alternatives EDAP Alternatives MLSS Alternatives MDAI Alternatives SURG Alternatives HYPR Alternatives NEPH Alternatives ICCM Alternatives APT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.The robotics revolution is here. And it's set to impact everything from how we manufacture goods to how we ...Weiss Ratings | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexGel, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexGel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.